Literature DB >> 25819225

Asbestos in Asia.

Su Lyn Leong1, Rizka Zainudin, Laurie Kazan-Allen, Bruce W Robinson.   

Abstract

Asbestos is a global killer. Despite lessons learned in the developed world on the use of asbestos and its hazardous pulmonary consequences, its use continues to increase in Asia. Although some countries such as Japan, Korea and Singapore have curtailed the use of this mineral, there are numerous countries in Asia that continue to mine, import and use this fibre, particularly China, which is one of the largest consumers in the world. Numerous factors ranging from political and economic to the lack of understanding of asbestos and the management of asbestos-related lung disease are keys to this observed trend. Awareness of these factors combined with early intervention may prevent the predicted Asian 'tsunami' of asbestos diseases.
© 2015 Asian Pacific Society of Respirology.

Entities:  

Keywords:  Asia; asbestos; asbestosis; mesothelioma

Mesh:

Substances:

Year:  2015        PMID: 25819225     DOI: 10.1111/resp.12517

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  13 in total

1.  A case from India of pleural malignant mesothelioma probably due to domestic and environmental asbestos exposure: a posthumous report.

Authors:  Venkiteswaran Muralidhar; Pankaja Raghav; Prianka Das; Akhil Goel
Journal:  BMJ Case Rep       Date:  2019-03-31

2.  Estimating the incidence of malignant mesothelioma in Vietnam: a pilot descriptive cancer registration study.

Authors:  Matthew J Soeberg; Mai Anh Luong; Van Thuan Tran; Anh Thanh Tran; Thị Thu Huyen Nguyen; Dieu Bui; Thi Hoai Nga Nguyen; Ken Takahashi; Nico van Zandwijk
Journal:  Int J Occup Environ Health       Date:  2016-07-08

3.  Clinical study of asbestos-related lung cancer diagnosed by asbestos medical examination.

Authors:  Takuma Yotsumoto; Atsushi Sano; Tsutomu Fukuda
Journal:  Cancer Rep (Hoboken)       Date:  2018-07-26

4.  Integrative Molecular Characterization of Malignant Pleural Mesothelioma.

Authors:  Julija Hmeljak; Francisco Sanchez-Vega; Katherine A Hoadley; Juliann Shih; Chip Stewart; David Heiman; Patrick Tarpey; Ludmila Danilova; Esther Drill; Ewan A Gibb; Reanne Bowlby; Rupa Kanchi; Hatice U Osmanbeyoglu; Yoshitaka Sekido; Jumpei Takeshita; Yulia Newton; Kiley Graim; Manaswi Gupta; Carl M Gay; Lixia Diao; David L Gibbs; Vesteinn Thorsson; Lisa Iype; Havish Kantheti; David T Severson; Gloria Ravegnini; Patrice Desmeules; Achim A Jungbluth; William D Travis; Sanja Dacic; Lucian R Chirieac; Françoise Galateau-Sallé; Junya Fujimoto; Aliya N Husain; Henrique C Silveira; Valerie W Rusch; Robert C Rintoul; Harvey Pass; Hedy Kindler; Marjorie G Zauderer; David J Kwiatkowski; Raphael Bueno; Anne S Tsao; Jenette Creaney; Tara Lichtenberg; Kristen Leraas; Jay Bowen; Ina Felau; Jean Claude Zenklusen; Rehan Akbani; Andrew D Cherniack; Lauren A Byers; Michael S Noble; Jonathan A Fletcher; A Gordon Robertson; Ronglai Shen; Hiroyuki Aburatani; Bruce W Robinson; Peter Campbell; Marc Ladanyi
Journal:  Cancer Discov       Date:  2018-10-15       Impact factor: 39.397

5.  Serum concentrations of Krebs von den Lungen-6, surfactant protein D, and matrix metalloproteinase-2 as diagnostic biomarkers in patients with asbestosis and silicosis: a case-control study.

Authors:  Changjiang Xue; Na Wu; Xue Li; Meihua Qiu; Xuqin Du; Qiao Ye
Journal:  BMC Pulm Med       Date:  2017-11-17       Impact factor: 3.317

6.  HEG1 is a novel mucin-like membrane protein that serves as a diagnostic and therapeutic target for malignant mesothelioma.

Authors:  Shoutaro Tsuji; Kota Washimi; Taihei Kageyama; Makiko Yamashita; Mitsuyo Yoshihara; Rieko Matsuura; Tomoyuki Yokose; Yoichi Kameda; Hiroyuki Hayashi; Takao Morohoshi; Yukio Tsuura; Toshikazu Yusa; Takashi Sato; Akira Togayachi; Hisashi Narimatsu; Toshinori Nagasaki; Kotaro Nakamoto; Yasuhiro Moriwaki; Hidemi Misawa; Kenzo Hiroshima; Yohei Miyagi; Kohzoh Imai
Journal:  Sci Rep       Date:  2017-03-31       Impact factor: 4.379

7.  Diagnostic value of soluble mesothelin-related peptides in pleural effusion for malignant pleural mesothelioma: An updated meta-analysis.

Authors:  Ruiyue Gao; Feng Wang; Zhen Wang; Yanbing Wu; Lili Xu; Yue Qin; Huanzhong Shi; Zhaohui Tong
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

8.  Global and regional burden of cancer in 2016 arising from occupational exposure to selected carcinogens: a systematic analysis for the Global Burden of Disease Study 2016.

Authors: 
Journal:  Occup Environ Med       Date:  2020-03       Impact factor: 4.402

9.  Challenging Global Waste Management - Bioremediation to Detoxify Asbestos.

Authors:  Shannon L Wallis; Edward A Emmett; Robyn Hardy; Brenda B Casper; Dan J Blanchon; Joseph R Testa; Craig W Menges; Cédric Gonneau; Douglas J Jerolmack; Ali Seiphoori; Gregor Steinhorn; Terri-Ann Berry
Journal:  Front Environ Sci       Date:  2020-03-04

10.  Patient-derived malignant pleural mesothelioma cell cultures: a tool to advance biomarker-driven treatments.

Authors:  Nikolaos I Kanellakis; Rachelle Asciak; Megat Abd Hamid; Xuan Yao; Mark McCole; Simon McGowan; Elena Seraia; Stephanie Hatch; Rob J Hallifax; Rachel M Mercer; Eihab O Bedawi; Stephanie Jones; Clare Verrill; Melissa Dobson; Vineeth George; Georgios T Stathopoulos; Yanchun Peng; Daniel Ebner; Tao Dong; Najib M Rahman; Ioannis Psallidas
Journal:  Thorax       Date:  2020-09-17       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.